×
Chemed Revenue 2010-2025 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Chemed revenue for the twelve months ending March 31, 2025 was
$2.489B
, a
8.52% increase
year-over-year.
Chemed annual revenue for 2024 was
$2.431B
, a
7.37% increase
from 2023.
Chemed annual revenue for 2023 was
$2.264B
, a
6.06% increase
from 2022.
Chemed annual revenue for 2022 was
$2.135B
, a
0.2% decline
from 2021.
View More
Chemed Revenue 2010-2025 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Chemed annual revenue for 2024 was
$2.431B
, a
7.37% increase
from 2023.
Chemed annual revenue for 2023 was
$2.264B
, a
6.06% increase
from 2022.
Chemed annual revenue for 2022 was
$2.135B
, a
0.2% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Quest Diagnostics (DGX)
$18.3B
DaVita (DVA)
$11.2B
Encompass Health (EHC)
$10.4B
Option Care Health (OPCH)
$5.3B
Elanco Animal Health (ELAN)
$4.2B
RadNet (RDNT)
$3.7B
Amedisys (AMED)
$3B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$1.8B
Astrana Health (ASTH)
$1.6B
U.S Physical Therapy (USPH)
$1B
Pennant (PNTG)
$907M
Aveanna Healthcare Holdings (AVAH)
$886M
Atai Life Sciences (ATAI)
$294M
Daxor (DXR)
$36M
Ontrak (OTRK)
$6M
MEDIROM Healthcare Technologies (MRM)
$4M
Psychemedics (PMD)
$0M